Epstein Secrets

tatives to put politics aside and pass something." White House Director of Strategic Communications Alyssa Farah said on Fox Bucinecc Mornings with Maria (10/22) , "This is really the most optimistic we've felt about getting a deal. There's still obviously some concerns. ... But we are seeing, I think

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

ntatives to put politics aside and pass something." White House Director of Strategic Communications Alyssa Farah said on Fox Business Mornings with Maria <https://video.foxbusiness.com/v/6203849111001/?playlist_id=3166411554001> (10/22) , "This is really the most optimistic we've felt about getting a

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a

atives to put politics aside and pass something." White House Director of Strategic Communications Alyssa Farah said on Fox Business Mornings with Maria (10/22) , "This is really the most optimistic we've felt about getting a deal. There's still obviously some concerns. ... But we are seeing, I think

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust